US Patent Reform Debate: Proposal To Eliminate BRI Patent Claim Standard Splits Stakeholders
Executive Summary
BIO and PhRMA want PTAB to give district courts deference in construing patent claims; Rep. Lofgren is concerned PTAB will be prohibited from doing its own claim construction and Mylan cites potential for inconsistencies within PTO.